Vincera Pharma Inc (VINC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.6480 +0.0280 (+4.52%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.6230 -0.0250 (-3.86%) 18:47 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,157 | -62,984 | -39,306 | -16,620 | -45 |
| Depreciation Amortization | 285 | 647 | 340 | 20 | N/A |
| Accounts payable and accrued liabilities | -1,568 | 1,046 | 1,528 | 456 | 35 |
| Other Working Capital | -4,191 | -1,020 | 5,609 | -959 | 44 |
| Other Operating Activity | 5,178 | 2,707 | -1,573 | 14,824 | -34 |
| Operating Cash Flow | $-40,453 | $-59,604 | $-33,402 | $-2,279 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -258 | N/A | N/A |
| Purchase Of Investment | -11,821 | -42,978 | N/A | N/A | N/A |
| Sale Of Investment | 53,321 | 2,400 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -5,000 | 0 | N/A |
| Other Investing Activity | 0 | 0 | -5,000 | 0 | 0 |
| Investing Cash Flow | $41,500 | $-40,578 | $-5,258 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 64,371 | N/A |
| Debt Repayment | N/A | N/A | N/A | -300 | N/A |
| Common Stock Issued | 114 | 280 | 88,453 | 0 | N/A |
| Financing Cash Flow | $114 | $280 | $88,453 | $64,071 | $N/A |
| Exchange Rate Effect | -40 | 71 | -21 | N/A | N/A |
| Beginning Cash Position | 11,733 | 111,564 | 61,792 | N/A | N/A |
| End Cash Position | 12,854 | 11,733 | 111,564 | 61,792 | N/A |
| Net Cash Flow | $1,121 | $-99,831 | $49,772 | $61,792 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,453 | -59,604 | -33,402 | -2,279 | 0 |
| Capital Expenditure | N/A | N/A | -258 | 0 | N/A |
| Free Cash Flow | -40,453 | -59,604 | -33,660 | -2,279 | 0 |